XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE DISCLOSURES (Tables)
 6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Weighted Average Interest Rate of Performing and All Loans
The following tables show the weighted-average interest rate of the performing loans and all loans:

For the three months endedFor the six months ended
Performing LoansJune 30, 2023June 30, 2022June 30, 2023June 30, 2022
Weighted-Average Interest Rate - Cash 13.11%20.28%12.12%16.07%
Weighted-Average Interest Rate- Non-Cash2.32%2.74%2.58%3.97%
Weighted-Average Interest Rate15.43%23.02%14.70%20.04%
For the three months endedFor the six months ended
All LoansJune 30, 2023June 30, 2022June 30, 2023June 30, 2022
Weighted-Average Interest Rate - Cash9.95%21.08%13.36%18.62%
Weighted-Average Interest Rate- Non-Cash1.68%2.52%2.00%3.69%
Weighted-Average Interest Rate11.63%23.60%15.36%22.31%
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The following tables provide quantitative information about the Fund’s Level 3 fair value measurements of the Fund’s investments by industry as of June 30, 2023 and December 31, 2022. In addition to the techniques and inputs noted in the tables below, the Fund may also use other valuation techniques and methodologies when determining its fair value measurements.
Investment Type - Level 3
Loan InvestmentsFair Value at
June 30, 2023		Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average (a)
Biotechnology$— Asset recoveryProbability Weighing of Alternative Outcomes100% *
Internet5,171,392Hypothetical market analysisHypothetical market coupon rate
11% - 21%
13%
Asset recoveryProbability Weighing of Alternative Outcomes
5% - 100%^
Medical Devices236,633Hypothetical market analysisHypothetical market coupon rate
 *
14%
Asset recoveryProbability Weighing of Alternative Outcomes
 100%*
Other Healthcare2,179,662Hypothetical market analysisHypothetical market coupon rate
12% - 14%
14%
Asset recoveryProbability Weighing of Alternative Outcomes100% *
Other Technology6,383,241Hypothetical market analysisHypothetical market coupon rate
11% - 34%
18%
Asset recoveryProbability Weighing of Alternative Outcomes
5% - 100%^
Software741,820Hypothetical market analysisHypothetical market coupon rate
*
13%
Asset recoveryProbability Weighing of Alternative Outcomes
10% - 100%
Technology Services340,719Asset recoveryProbability Weighing of Alternative Outcomes
5% - 100%
Total Loan Investments$15,053,467 

(a) The weighted average hypothetical market coupon rates were calculated using the fair value of the loans.
* There is only one loan within the industry.
^ Probability weightings vary among portfolio companies within each industry based on different potential future outcomes.
Investment Type - Level 3
Loan InvestmentsFair Values at
December 31, 2022		Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average (a)
Biotechnology$1,732,373 Hypothetical market analysisHypothetical market coupon rate14%14%
Asset RecoveryProbability weighting of alternative outcomes100% *
Computers and Storage282,621 Hypothetical market analysisHypothetical market coupon rate*15%
Internet6,241,043 Hypothetical market analysisHypothetical market coupon rate
11% - 22%
13%
Asset RecoveryProbability weighting of alternative outcomes
5% - 100% ^
Medical Devices3,870,685 Hypothetical market analysisHypothetical market coupon rate
13% - 14%
14%
Asset RecoveryProbability weighting of alternative outcomes
5% - 100% ^
Other Healthcare4,962,393 Hypothetical market analysisHypothetical market coupon rate
13% - 15%
15%
Asset RecoveryProbability weighting of alternative outcomes
100%^
Other Technology16,116,947 Hypothetical market analysisHypothetical market coupon rate
14% - 34%
17%
Asset RecoveryProbability weighting of alternative outcomes
1% - 100% ^
Software2,576,312 Hypothetical market analysisHypothetical market coupon rate
13% - 18%
15%
Asset RecoveryProbability weighting of alternative outcomes
5% -100%^
Technology Services400,762 Hypothetical market analysisHypothetical market coupon rate*18%
Asset RecoveryProbability weighting of alternative outcomes
3% - 60% ^
Total Loan Investments$36,183,136 
(a) The weighted average hypothetical market coupon rates were calculated using the fair value of the loans.
* There is only one loan within the industry.
^ Probability weightings vary among portfolio companies within each industry based on different potential future outcomes.
Assets and Liabilities Measured At Fair Value On Recurring Basis
The following tables present the balances of assets and liabilities as of June 30, 2023 and December 31, 2022 measured at fair value on a recurring basis:

As of June 30, 2023
ASSETS:Level 1Level 2Level 3Total
Loans†
$— $— $15,053,467 $15,053,467 
Cash equivalents13,825,807 — — 13,825,807 
Total assets$13,825,807 $— $15,053,467 $28,879,274 
As of December 31, 2022
ASSETS:Level 1Level 2Level 3Total
Loans†
$— $— $36,183,136 $36,183,136 
Cash equivalents3,135,402 — — 3,135,402 
Total assets$3,135,402 $— $36,183,136 $39,318,538 

† For a detailed listing of borrowers comprising this amount, please refer to the Condensed Schedules of Investments.
Summary of Changes in Level 3 Assets Measured At Fair Value on Recurring Basis
The following tables provide a summary of changes in Level 3 assets measured at fair value on a recurring basis:
For the Three Months Ended
June 30, 2023		  For the Six Months Ended
June 30, 2023
LoansWarrantsLoansWarrants
Beginning balance$23,810,122 $— $36,183,136 $— 
Acquisitions and originations— 232,590 — 280,475 
Principal payments on loans, net of accretion(8,832,203)— (21,059,183)— 
Distributions to shareholder — (232,590)— (280,475)
Net change in unrealized gain from loans70,068 — 585,375 — 
Net realized gain (loss) from loans5,480 — (655,861)— 
Ending balance$15,053,467 $— $15,053,467 $— 
Net change in unrealized gain (loss) from loans relating to loans still held at June 30, 2023$70,068 $(213,120)

For the Three Months Ended
June 30, 2022		For the Six Months Ended
June 30, 2022
LoansWarrantsLoansWarrantsStocks
Beginning balance$89,617,574 $— $108,465,616 $— $— 
Acquisitions and originations— 67,910 — 100,172 2,090,759 
Principal payments on loans, net of accretion(28,645,452)— (49,252,086)— — 
Distributions to shareholder— (67,910)— (100,172)(2,090,759)
Net change in unrealized gain from loans1,433,959 — 3,822,491 — — 
Net realized loss from loans(1,063,601)— (1,693,541)— — 
Ending balance$61,342,480 $— $61,342,480 $— $— 
Net change in unrealized gain from loans relating to loans still held at June 30, 2022$573,918 $1,389,334